NCT00723502
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Dyspepsia, +6 more
- Locations
-
- Dr. Hein Marburg, Germany
Clinical trial condition
Dyspepsia
Explore clinical trials studying Dyspepsia. Study availability and eligibility vary by location and protocol.
189 public trials
22 recruiting studies
Dyspepsia trial results
NCT00275743
- Conditions
- Dyspepsia, Healthy Volunteers, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00243724
- Conditions
- Deglutition Disorders, Digestive System Diseases, Dyspepsia, +8 more
- Locations
-
- Research Site Vancouver, British Columbia, Canada
- Research Site Halifax, Nova Scotia, Canada
- Research Site Guelph, Ontario, Canada
- Research Site Hamilton, Ontario, Canada
Completed
Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion
NCT00843063
- Conditions
- Digestive System Diseases, Duodenal Diseases, Dyspepsia, +11 more
- Locations
-
- Ruttonjee Hospital Wan Chai, Hong Kong, China
NCT00298194
- Conditions
- Dyspepsia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +1 more
- Locations
-
- Royal Adelaide Hospital Adelaide, South Australia, Australia
NCT00292578
- Conditions
- Allergy, Dyspepsia, Fatigue, +11 more
- Locations
-
- 6714-32 Beach Blvd., Buena Park, California, United States
NCT00328679
- Conditions
- Dyspepsia, Food Hypersensitivity, Hypersensitivity, +5 more
- Locations
-
- The Children's Mercy Hospital and Clinics Kansas City, Missouri, United States
NCT00217347
- Conditions
- Deglutition Disorders, Digestive System Diseases, Dyspepsia, +8 more
- Locations
-
- Nantes University Hospital Nantes, France
Completed
Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children
NCT00521703
- Conditions
- Abdominal Pain, Deglutition Disorders, Digestive System Diseases, +16 more
- Locations
-
- Hospital Infantil Cândido Fontoura São Paulo, Brazil
Completed
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
NCT00232024
- Conditions
- Dyspepsia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +1 more
- Locations
-
- Novartis East Hanover, New Jersey, United States